IPCALABNSEIPCA Laboratories Limited· PharmaceuticalsHighPositive
Announced Thu, 29 May · 13:58 IST

IPCA Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2025, recommended Final Dividend of Rs. 2 per equity share.

Corporate Actions View source PDF

IPCALAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board of Directors of Ipca Laboratories, at its meeting held on May 29, 2025, has recommended a Final Dividend of Rs. 2 per equity share for the financial year. This dividend is subject to approval by the company's shareholders at the upcoming Annual General Meeting. The record date and book closure dates for determining eligible shareholders will be announced separately. The final dividend would be paid over and above any interim dividend already declared during the year.

Likely market impact

A Rs. 2 per share final dividend translates to a modest payout and is unlikely to materially impact the stock price. It signals steady, predictable shareholder returns rather than a major capital distribution event.